Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (181-190 of 243) with videos related to

Pageof 25
Sort By:
Psycho-Oncology|March 20, 2017
Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort studyYves Libert, Cindy Borghgraef, Yves Beguin, et al.
Psycho-Oncology|March 5, 2016
Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory studyYves Libert, Cindy Borghgraef, Yves Beguin, et al.
Transplantation|March 14, 2015
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular TherapyJordan Gauthier, Gandhi Damaj, Carole Langlois, et al.
Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
European Journal of Haematology|August 19, 2014
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)Thierry Guillaume, Yves Beguin, Reza Tabrizi, et al.
Leukemia|July 28, 2018
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationNicole Engel, Alicia Rovo, Manuela Badoglio, et al.
Oncotarget|January 20, 2018
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMTGabrielle Roth-Guepin, Jonathan Canaani, Annalisa Ruggeri, et al.
Cancer Cell|February 16, 2022
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipientsLorenzo Canti, Kevin K Ariën, Isabelle Desombere, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyDaniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.
Pageof 25

Showing results (181-190 of 243) with videos related to

Sort By:
Pageof 25
Psycho-Oncology|March 20, 2017
Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort studyYves Libert, Cindy Borghgraef, Yves Beguin, et al.
Psycho-Oncology|March 5, 2016
Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory studyYves Libert, Cindy Borghgraef, Yves Beguin, et al.
Transplantation|March 14, 2015
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular TherapyJordan Gauthier, Gandhi Damaj, Carole Langlois, et al.
Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
European Journal of Haematology|August 19, 2014
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)Thierry Guillaume, Yves Beguin, Reza Tabrizi, et al.
Leukemia|July 28, 2018
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationNicole Engel, Alicia Rovo, Manuela Badoglio, et al.
Oncotarget|January 20, 2018
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMTGabrielle Roth-Guepin, Jonathan Canaani, Annalisa Ruggeri, et al.
Cancer Cell|February 16, 2022
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipientsLorenzo Canti, Kevin K Ariën, Isabelle Desombere, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyDaniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.
Pageof 25